| Patents for A61K 49 - Preparations for testing in vivo (35,376) |
|---|
| 07/18/2001 | EP0639083B1 Complexing agents and targeting immunoreagents |
| 07/18/2001 | EP0616508B1 Gas filled liposomes and their use as ultrasonic contrast agents |
| 07/18/2001 | CN1304446A Poly (ADP-ribose) polymerse gene |
| 07/17/2001 | US6262335 Transgenic mice expressing APP mutant at amino acids 717, 721 and 722 |
| 07/17/2001 | US6261558 Synthetic human neutralizing monoclonal antibodies to human immunodeficiency virus |
| 07/17/2001 | US6261548 Polypeptides for leukemia inhibitor factors with amino acid sequences |
| 07/17/2001 | US6261537 Targets and ultrasound diagnosis of active materials, aqueous carrier liquids, carriers and film forming surfactant phosphatides |
| 07/17/2001 | US6261535 Images of tumors |
| 07/12/2001 | WO2001049326A1 Use of contrast agents in the manufacture of diagnostic agent for the visualisation of the intestinal lumen |
| 07/12/2001 | WO2001049318A1 Novel chimeric proteins and methods for using the same |
| 07/12/2001 | WO2001049184A2 Radiofrequency apparatus and method for accessing a biopsy site |
| 07/12/2001 | WO2000078774A3 Induction of pharmacological stress with adenosine receptor agonists |
| 07/12/2001 | WO2000037114A9 Methods and compositions comprising monitoring devices |
| 07/12/2001 | WO1999052541A3 Artery- and vein-specific proteins and uses therefor |
| 07/12/2001 | CA2395945A1 Novel chimeric proteins and methods for using the same |
| 07/12/2001 | CA2395225A1 Apparatus and method for accessing a biopsy site |
| 07/11/2001 | EP1113823A2 Chiral radio-contrast agents |
| 07/11/2001 | EP1113822A1 Near infrared fluorescent contrast agent and fluorescence imaging |
| 07/11/2001 | EP0731808B1 Nucleosides and oligonucleotides containing boron clusters |
| 07/11/2001 | CN1303430A FAP alpha specific antibody with improved producibility |
| 07/11/2001 | CN1303393A Specific binding molecules for scintigraphy, conjugates containing them and therapeutic method for treatment of angiogenesis |
| 07/11/2001 | CN1303289A Adenosine A3 receptor modulators |
| 07/11/2001 | CN1303273A Use of particulate contrast agents in diagnostic imaging for studying physiological parameters |
| 07/11/2001 | CN1068230C Phase shift colloids as ultrasound contrast agents |
| 07/11/2001 | CN1068229C Ultrasonic contrast medium, contrast agent containing this medium and method |
| 07/10/2001 | US6258378 Delivery of biologically active substance to target sites in the body of patients |
| 07/10/2001 | US6258340 Using water-soluble dyes and their biomolecule adducts each having specific photophysical and pharmochemical properties |
| 07/10/2001 | US6258339 Injectable ultrasound contrast enhancement agents of different density and higher compressibility than the surrounding fluid |
| 07/10/2001 | US6258032 Method of diagnosis and treatment and related compositions and apparatus |
| 07/05/2001 | WO2001048477A1 Method of cancer screening primarily utilizing non-invasive cell collection and fluorescence detection techniques |
| 07/05/2001 | WO2001047564A2 Labelled ascorbic acid derivatives |
| 07/05/2001 | WO2001047510A2 Methods and compositions related to modulators of annexin and cartilage homeostasis |
| 07/05/2001 | WO2000071162A3 Cyanine and indocyanine dye bioconjugates for biomedical applications |
| 07/05/2001 | US20010006618 Intraoperative, intravascular and endoscopic tumor and lesion detection, biopsy and therapy |
| 07/05/2001 | US20010006617 Formulations for therapeutic agents absorbed through mucous membranes |
| 07/05/2001 | CA2394959A1 Labelled ascorbic acid derivatives |
| 07/04/2001 | EP1113020A2 Nucleosides and oligonucleotides containing boron clusters |
| 07/04/2001 | EP1112254A2 Cyanine dyes and synthesis methods thereof |
| 07/04/2001 | EP1112077A1 Method for detection of biological factors in epidermis |
| 07/04/2001 | EP1007628A4 Transgenic model for heart failure |
| 07/04/2001 | CN1302211A Improvements in/or relating to diagnostic/therapeutic agent |
| 07/03/2001 | US6256527 Method for determining oxygen concentration |
| 07/03/2001 | US6254852 Porous inorganic targeted ultrasound contrast agents |
| 07/03/2001 | US6254851 Diagnostic agents for pancreatic exocrine function |
| 07/03/2001 | US6254850 Polycarboxyalkylaminoalkanes for complexes |
| 07/03/2001 | CA2107466C Low density microspheres and their use as contrast agents for computed tomography |
| 07/03/2001 | CA2012993C Monoclonal antibodies (mabs) against tumor-associated antigens, the preparation and use thereof |
| 06/28/2001 | WO2001046207A1 Chelating compounds, their complexes with paramagnetic metals |
| 06/28/2001 | WO2000078776A3 Thiophene a2a receptor agonists |
| 06/28/2001 | WO2000073344A3 Monoclonal antibodies, synthetic and biotechnological derivatives thereof acting as ngf-antagonist molecules |
| 06/28/2001 | DE19964224A1 New calcium complex of oxa-diaza-phosphaundecane derivative MS-325, useful as stabilizer for diagnostic compositions containing gadolinium complex of MS-325 and as antidote for heavy metal poisoning |
| 06/28/2001 | DE10006366A1 Determining the acid-base balance of an animal or human comprises applying a pH indicator to the skin and observing the color change |
| 06/27/2001 | EP1111389A1 Use of an antibody specific for papillary fibroblasts as a marker for skin quality |
| 06/27/2001 | EP1110963A2 Chlorin and bacteriochlorin-based aminophenyl DTPA and N2S2 conjugates for MR contrast media and radiopharmaceuticals |
| 06/27/2001 | EP1110945A2 Azocompounds for the antemortem diagnosis of Alzheimer's disease and in vivo imaging and prevention of amyloid deposition |
| 06/27/2001 | EP1110091A1 Immunodiagnostics using particle delivery methods |
| 06/27/2001 | EP1109937A1 A novel method of diagnosing, monitoring, staging, imaging and treating various cancers |
| 06/27/2001 | EP1109909A2 Grf analogs with increased biological potency |
| 06/27/2001 | EP1109900A1 Angiocidin: a cys-ser-val-thr-cys-gly specific tumor cell adhesion receptor |
| 06/27/2001 | EP1109795A1 Thiazoline acid derivatives |
| 06/27/2001 | EP0603403B2 Novel chelating agent, complex compound composed of said agent and metallic atom, and diagnostic agent containing said compound |
| 06/26/2001 | US6252087 Complexing with a protein |
| 06/26/2001 | US6252043 Fusion protein for the treatment of inflammation; for the detection and prevention of leukocyte adhesion to endothelial cells |
| 06/26/2001 | US6251587 Evaluating humans diagnosed with nervous system disorders; diagnose human with defect, determine genotype or phenotype of human, classify nervous system disorders |
| 06/26/2001 | US6251394 Method and a system for enhanced in vivo clearance of diagnostic and/or therapeutic agents by extracorporeal depletion, and the use of said agents for said purpose |
| 06/26/2001 | US6251384 Metastasis models using green fluorescent protein (GFP) as a marker |
| 06/26/2001 | US6251367 Porphyrin complexes with metals |
| 06/26/2001 | US6251366 Superparamagnetic solid particles, polyelectrolyte as dispersants for magnetic resonance imaging |
| 06/26/2001 | US6251365 Magnetite monocrystals and phosphatide membranes |
| 06/26/2001 | US6250306 Assessment of ischemic wound healing therapeutics |
| 06/26/2001 | CA2245461C Detection of conditions or diseases associated with an altered level of telomerase activity |
| 06/21/2001 | WO2001044243A2 Novel heteroaryl-diazabicycloalkanes |
| 06/21/2001 | WO2001043781A1 Near infrared fluorescent contrast agent and fluorescence imaging |
| 06/21/2001 | WO2001013892A3 Large porous particles by spray-drying |
| 06/21/2001 | WO2000061191A9 Heat stable coated colloidal iron oxides |
| 06/21/2001 | US20010004529 Compositions to enhance the efficacy and safety of bio-pharmaceutical drugs |
| 06/21/2001 | US20010004454 Metal complexes derivatized with folate for use in diagnostic and therapeutic applications |
| 06/21/2001 | US20010004395 Fiducial marker |
| 06/20/2001 | EP1107979A2 Lipid matrix-assisted chemical ligation and synthesis of membrane polypeptides |
| 06/20/2001 | EP1107799A1 Method for labeling biopolymers using isotopes |
| 06/20/2001 | EP1107798A1 A novel method of diagnosing, monitoring, staging, imaging and treating colon cancer |
| 06/20/2001 | EP1107743A1 Stable spray-dried protein formulations |
| 06/19/2001 | US6249331 Methods for forming an orientation layer on LCD panels |
| 06/19/2001 | US6248933 Cellular basis of vascular-graft stenosis |
| 06/19/2001 | US6248727 Systemically administered diagnostic reagent for visualizing and occluding a blood vessel in a mammal comprising a liposome-encapsulated fluorescent dye releaseable at body temperature, a tissue reactive agent and a carrier |
| 06/19/2001 | US6248712 Urokinase-type plasminogen activator receptor |
| 06/19/2001 | US6248531 Trans-platinum compound, and diagnostic kit |
| 06/19/2001 | US6248306 Cascade polymer complexes, process for their production and pharmaceutical agents containing said complexes |
| 06/19/2001 | US6248305 Boron heterocycle steroid mimics and associated pharmaceutical compositions and methods of use |
| 06/19/2001 | US6247473 System and method for testing the neuroprotective or neuroregenerative effects of drugs |
| 06/19/2001 | CA1341259C Particle vector useful as a carrier of biologically active molecules, and a fabrication method |
| 06/14/2001 | WO2001042220A2 Podate ligands and methods of use thereof |
| 06/14/2001 | WO2001041816A2 Microparticles based on aspartic acid and use thereof as mri contrast agents |
| 06/14/2001 | WO2001041811A2 Carrier peptide and method for delivery of molecules into cells |
| 06/14/2001 | WO2001041640A1 Use of poly-nitroxyl-functionalized dendrimers as contrast enhancing agents in mri imaging of joints |
| 06/14/2001 | WO2001019409A3 Method of tumor imaging |
| 06/14/2001 | WO2000035950A9 Reagents and methods useful for detecting diseases of the breast |
| 06/14/2001 | US20010003791 Ultrasonic and x-ray detectable biopsy site marker and apparatus for applying it |
| 06/14/2001 | US20010003580 Dissolving a lipid blend in a nonaqueous solvent and adding it to water or an aqueous solution of brine and/or glycerin and/or solvent; uniform particle size; ultrasound contrast agents |
| 06/13/2001 | EP1106187A2 Microparticles as ultrasonic contrast media |